Baby Boomers looking to put new money to work may wish to check out the broader basket of dividend stocks while interest ...

Starboard Value may have lost its first skirmish with Pfizer. But the activist investor has a track record of protracted, ...

Speculation surrounds the reversal, with Jeff Smith, CEO of Starboard, claiming Pfizer pressured the ex-executives with ...

Now, despite playing no formal role in the battle between Pfizer and Starboard, Guggenheim has found itself in the crossfire of one of the messiest activist campaigns in recent Wall Street memory.

Pfizer appointed a former chief executive officer at Vanguard, the drug giant's biggest investor, to its board on Tuesday as ...

On Wednesday, Bourla is expected to sit down with Starboard after reports early last week that the investment firm had ...

Will this clash between a major shareholder and management, current and former, harm the stock? Or is the situation merely an ...

Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...

Companies like Amazon have required a return to the office five days a week despite findings showing benefits to employers ...

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add ...

Activist investor Starboard Value accused Pfizer of pressuring its former CEO Ian Read and ex-CFO Frank D’Amelio to halt ...

Here are some of the major companies whose stocks moved on the week’s news.